LODH Immunology Fund

Summary

The venture was found in Europe in Switzerland. The leading representative office of defined Corporate Investor is situated in the Geneva.

For fund there is no match between the location of its establishment and the land of its numerous investments - Denmark. Among the most popular portfolio startups of the fund, we may highlight Genmab, 7TM Pharma, ESBATech. The fund has specific favorite in a number of founders of portfolio startups. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular fund investment industries, there are Health Care, Therapeutics.

Speaking about the real fund results, this Corporate Investor is 3 percentage points less often commits exit comparing to other organizations. Comparing to the other companies, this LODH Immunology Fund performs on 4 percentage points more the average number of lead investments. The increased amount of exits for fund were in 2019. The high activity for fund was in 2000. The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the LODH Immunology Fund, startups are often financed by Reference Capital SA, Novartis Venture Fund, Pictet Private Equity Investors S.A.. The meaningful sponsors for the fund in investment in the same round are Novartis Venture Fund, Pictet Private Equity Investors S.A., Index Ventures. In the next rounds fund is usually obtained by Novartis Venture Fund, BZ Bank, VI Partners AG.